AXL kinase as a novel target for cancer therapy-Reference-Cited by-同舟云学术

AXL kinase as a novel target for cancer therapy

Published:2014-10-16 Issue:20 Volume:5 Page:9546-9563
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wu Xiaoliang¹,Liu Xuewen¹²,Koul Sanjay²,Lee Chang Youl³,Zhang Zhenfeng¹,Halmos Balazs²

Affiliation:

1. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

2. Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital-Columbia University Medical Center, New York, NY, USA

3. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Chuncheon Sacred Heart Hospital Hallym University Medical Center, Chuncheon-si Gangwon-do 200-704 Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evaluation of the interaction of baicalein (5,6,7-trihydroxyflavone) with human IgG and a glioblastoma multiforme (GBM) cell line;Arabian Journal of Chemistry;2024-10

2. Elucidating the phosphoregulatory network of predominant phosphosite in AXL kinase: an integrative bioinformatic approach;Journal of Proteins and Proteomics;2024-06-19

3. In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier for C−2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers;Pharmacological Reports;2024-06-18

4. m6A reader YTHDF1 promotes cardiac fibrosis by enhancing AXL translation;Frontiers of Medicine;2024-05-28

5. Azaindole derivatives as potential kinase inhibitors and their SARs elucidation;European Journal of Medicinal Chemistry;2023-10